Gigamon (GIMO) Drops 8.28% on February 05

Equities Staff |

Gigamon (GIMO) was one of the Russell 2000's biggest losers for Friday February 05 as the stock slid 8.28% to $23.25, a loss of $-2.1 per share. Starting at an opening price of $25.00 a share, the stock traded between $22.91 and $25.00 over the course of the trading day. Volume was 295,410 shares over 2,666 trades, against an average daily volume of 394,670 shares and a total float of 34.02 million.

The losses send Gigamon down to a market cap of $791.02 million. In the last year, Gigamon has traded between $34.80 and $18.78, and its 50-day SMA is currently $25.57 and 200-day SMA is $27.08.

The stock has a P/E Ratio of 128.9.

Gigamon Inc develops a solution that delivers visibility of traffic across networks. Its solution, Unified Visibility Fabric, consists of a distributed system of nodes that enables level of visibility, modification and control of network traffic.

Gigamon is based out of Santa Clara, CA and has some 371 employees. Its CEO is Paul A. Hooper.

For a complete fundamental analysis analysis of Gigamon, check out Equities.com’s Stock Valuation Analysis report for GIMO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…